abstract = "The success of a drug treatment is strongly correlated
with the ability of a molecule to reach its target in
the patient's organism without inducing toxic effects.
Moreover the reduction of cost and time associated with
drug discovery and development is becoming a crucial
requirement for pharmaceutical industry. Therefore
computational methods allowing reliable predictions of
newly synthesised compounds properties are of utmost
relevance. In this talk, I discuss the role of Genetic
Programming (GP) in predictive pharmacokinetics,
considering the estimation of adsorption, distribution,
metabolism, excretion and toxicity processes (ADMET)
that a drug undergoes into the patient's organism. In
particular, I discuss the ability of GP to predict oral
bioavailability (F), median oral lethal dose (LD50) and
plasma-protein binding levels (PPB). Since these
parameters respectively characterise the percentage of
initial drug dose that effectively reaches the systemic
blood circulation, the harmful effects and the
distribution into the organism of a drug, they are
essential for the selection of potentially effective
molecules. In the last part of the talk, I show and
discuss how recently defined geometric semantic genetic
operators can dramatically affect the performances of
GP for this kind of application, in particular on
out-of-sample test data.",
notes = "Only abstract in proceedings. See also
\cite{Freitas:2013:NICSO}
http://www.nicso2013.org/programme.html